Predica Diagnostics is a medical‑diagnostics startup (a spin‑off from RadboudUMC) that develops and markets assays for oncology and women’s health using their proprietary targeted RNA‑sequencing technology (ciRNAseq).

Their first product, CervicaDx, aims to improve cervical cancer screening by providing non‑invasive, high‑specificity detection of cervical abnormalities, reducing overdiagnosis and overtreatment compared to current HPV‑based tests. Their mission is to ensure patients only undergo medically necessary procedures — by offering more precise diagnostics and treatment guidance.